HYPOGLYCAEMIC ENCEPHALOPATHY

This adverse event was reported 389 times

HYPOGLYCAEMIC ENCEPHALOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIGLITOL 7 0.0073
1 FLUDEOXYGLUCOSE F-18 1 0.0035
2 IBUPROFEN LYSINE 1 0.0018
3 ALOGLIPTIN 6 0.0018
4 REPAGLINIDE 13 0.0017
5 SELEGILINE HYDROCHLORIDE 1 0.0017
6 ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID 1 0.0016
7 BROMOCRIPTINE MESYLATE 1 0.0015
8 HUMAN INSULIN 11 0.0015
9 SITAGLIPTIN PHOSPHATE 4 0.0015
See all drugs enriched for association with HYPOGLYCAEMIC ENCEPHALOPATHY

HYPOGLYCAEMIC ENCEPHALOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 alpha-Glucosidase Inhibitor [EPC] 12 0.0025
1 Glinide [EPC] 13 0.0015
2 Sulfonylurea [EPC] 72 0.0006
3 Insulin [EPC] 24 0.0005
4 Nitrogen Binding Agent [EPC] 1 0.0004
5 Neuraminidase Inhibitor [EPC] 1 0.0004
6 Dipeptidyl Peptidase 4 Inhibitor [EPC] 12 0.0004
7 Radioactive Diagnostic Agent [EPC] 1 0.0003
8 Chloride Channel Activator [EPC] 3 0.0003
9 Insulin Analog [EPC] 107 0.0002
See all drug classes enriched for association with HYPOGLYCAEMIC ENCEPHALOPATHY